Spontaneous viral load decline and subsequent clearance of chronic hepatitis c virus in postpartum women correlates with favorable interleukin-28B gene allele

Clinical Infectious Diseases

Volumn 65, Issue 6, 2017, Pages 999-1005

  Hashem, Mohamed ^a   Jhaveri, Ravi ^b   Saleh, Doa'a A ^c   Sharaf, Sahar A ^d   El Mougy, Fatma ^d   Abdelsalam, Lobna ^d   Shardell, Michelle D ^e   El Ghazaly, Hesham ^f   El Kamary, Samer S ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Departments of Public Health and Community Medicine   (United States)

^d CAIRO UNIVERSITY   (Egypt)

^e NATIONAL INSTITUTE ON AGING   (United States)

^f CAIRO UNIVERSITY   (Egypt)

Author keywords

Hepatitis c virus; IL28B; Pregnancy; Spontaneous clearance; Viral clearance

Indexed keywords

HEPATITIS C ANTIBODY; INTERLEUKIN 28B; VIRUS RNA; IL28B PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ADULT; ALLELE; ARTICLE; CHRONIC HEPATITIS C; COHORT ANALYSIS; DEMOGRAPHY; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; NONHUMAN; PREDICTIVE VALUE; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUERPERIUM; RISK FACTOR; SENSITIVITY AND SPECIFICITY; VIRAL CLEARANCE; VIRUS LOAD; BLOOD; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; PREGNANCY COMPLICATION; REMISSION; TIME FACTOR;

ADULT; ALLELES; FEMALE; GENOTYPE; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; INTERLEUKINS; POLYMORPHISM, GENETIC; POSTPARTUM PERIOD; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; REMISSION, SPONTANEOUS; RNA, VIRAL; TIME FACTORS; VIRAL LOAD;

EID: 85031914198     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix445     Document Type: Article

References (37)

1. Ceci O, Margiotta M, Marello F, et al. Vertical transmission of hepatitis C virus in a cohort of 2, 447 HIV-seronegative pregnant women: A 24-month prospective study. J Pediatr Gastroenterol Nutr 2001; 33:570-5.
2. Shebl FM, El-Kamary SS, Saleh DA, et al. Prospective cohort study of mother-To-infant infection and clearance of hepatitis C in rural Egyptian villages. J Med Virol 2009; 81:1024-31.
3. Yeung LT, To T, King SM, Roberts EA. Spontaneous clearance of childhood hepatitis C virus infection. J Viral Hepat 2007; 14:797-805.
4. Mast EE, Hwang LY, Seto DS, et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis 2005; 192:1880-9.
5. Irshad M, Khushboo I, Singh S, Singh S. Hepatitis C virus (HCV): A review of immunological aspects. Int Rev Immunol 2008; 27:497-517.
6. Raghuraman S, Park H, Osburn WO, Winkelstein E, Edlin BR, Rehermann B. Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion. J Infect Dis 2012; 205:763-71.
7. Rehermann B. Hepatitis C virus versus innate and adaptive immune responses: A tale of coevolution and coexistence. J Clin Invest 2009; 119:1745-54.
8. Hattori Y, Orito E, Ohno T, et al. Loss of hepatitis C virus RNA after parturition in female patients with chronic HCV infection. J Med Virol 2003; 71:205-11.
9. Lin HH, Kao JH. Hepatitis C virus load during pregnancy and puerperium. BJOG 2000; 107:1503-6.
10. Honegger JR, Kim S, Price AA, et al. Loss of immune escape mutations during persistent HCV infection in pregnancy enhances replication of vertically transmitted viruses. Nat Med 2013; 19:1529-33.
11. Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009; 461:399-401.
12. Thomas DL, Thio CL, Martin MP, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009; 461:798-801.
13. Nattermann J, Timm J, Nischalke HD, et al; East German HCV Study Group. The predictive value of IL28B gene polymorphism for spontaneous clearance in a single source outbreak cohort is limited in patients carrying the CCR5Δ32 mutation. J Hepatol 2011; 55:1201-6.
14. Shi X, Pan Y, Wang M, et al. IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population. PLoS One 2012; 7:e37054.
15. Takaki A, Wiese M, Maertens G, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 2000; 6:578-82.
16. Kandeel A, Genedy M, El-Refai S, Funk AL, Fontanet A, Talaat M. The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment. Liver Int 2017 January; 37(1):45-53.
17. El-Kamary SS, Hashem M, Saleh DA, et al. Reliability of risk-based screening for hepatitis C virus infection among pregnant women in Egypt. J Infect 2015; 70:512-9.
18. Jhaveri R, Hashem M, El-Kamary SS, et al. Hepatitis C virus (HCV) vertical transmission in 12-month-old infants born to HCV-infected women and assessment of maternal risk factors. Open Forum Infect Dis 2015; 2:ofv089.
19. Schroter M, Zollner B, Schafer P, Laufs R, Feucht HH. Quantitative detection of hepatitis C virus RNA by light cycler PCR and comparison with two different PCR assays. J Clin Microbiol 2001; 39:765-8.
20. Boyer S. Papers on human genetics. Englewood Cliffs, N.J.: Prentice-Hall, 1963.
21. Hardy GH. Mendelian proportions in a mixed population. 1908. Yale J Biol Med 2003; 76:79-80.
22. Abdelwahab SF, Zakaria Z, Sobhy M, et al. Differential distribution of IL28B. rs12979860 single-nucleotide polymorphism among Egyptian healthcare workers with and without a hepatitis C virus-specific cellular immune response. Arch Virol 2015; 160:1741-50.
23. Carapito R, Poustchi H, Kwemou M, et al. Polymorphisms in EGFR and IL28B are associated with spontaneous clearance in an HCV-infected Iranian population. Genes Immun 2015; 16:514-8.
24. Ezzikouri S, Alaoui R, Rebbani K, et al. Genetic variation in the interleukin-28B gene is associated with spontaneous clearance and progression of hepatitis C virus in Moroccan patients. PLoS One 2013; 8:e54793.
25. Kurbanov F, Abdel-Hamid M, Latanich R, et al. Genetic polymorphism in IL28B is associated with spontaneous clearance of hepatitis C virus genotype 4 infection in an Egyptian cohort. J Infect Dis 2011; 204:1391-4.
26. European Paediatric Hepatitis C Virus Network. A significant sex-but not elective cesarean section-effect on mother-To-child transmission of hepatitis C virus infection. J Infect Dis 2005; 192:1872-9.
27. El-Kamary SS, Hashem M, Saleh DA, et al. Reliability of risk-based screening for hepatitis C virus infection among pregnant women in Egypt. J Infect 2015; 70:512-9.
28. Deuffic-Burban S, Castel H, Wiegand J, et al. Immediate vs. delayed treatment in patients with acute hepatitis C based on IL28B polymorphism: A model-based analysis. J Hepatol 2012; 57:260-6.
29. Mangia A, Santoro R, Copetti M, et al. Treatment optimization and prediction of HCV clearance in patients with acute HCV infection. J Hepatol 2013; 59:221-8.
30. Hayes CN, Imamura M, Aikata H, Chayama K. Genetics of IL28B and HCV- response to infection and treatment. Nat Rev Gastroenterol Hepatol 2012; 9:406-17.
31. Urban TJ, Thompson AJ, Bradrick SS, et al. IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C. Hepatology 2010; 52:1888-96.
32. Afdhal N, Reddy KR, Nelson DR, et al; ION-2 Investigators. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. N Engl J Med 2014; 370:1483-93.
33. Feld JJ, Kowdley KV, Coakley E, et al. Treatment of HCV with ABT-450/rombitasvir and dasabuvir with ribavirin. N Engl J Med 2014; 370:1594-603.
34. American Association for the Study of Liver D. Recommendations for testing, managing, and treating hepatitis C. 2017. Available at: http://hcvguidelines.org/sites/default/files/HCV-Guidance-April-2017-A.pdf Accessed 9 June 2017.
35. Guleria I, Sayegh MH. Maternal acceptance of the fetus: True human tolerance. J Immunol 2007; 178:3345-51.
36. Honegger JR, Tedesco D, Kohout JA, et al. Influence of IFNL3 and HLA-DPB1 genotype on postpartum control of hepatitis C virus replication and T-cell recovery. Proc Natl Acad Sci U S A 2016; 113:10684-9.
37. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 2014; 61(1 Suppl):S45-S57.